Our results based on tests of saliva samples from 131 oral cancer patients and 199 control cases showed that MMP-1 had a sensitivity of 69.5% and specificity of 95.0%, whereas CD44 had a sensitivity of 76.3% and specificity of 57.8%. Here, CD44 is linked to lip and oral cavity carcinoma.